The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia

被引:41
|
作者
Choi, KH
Lee, HB
Jeong, MY
Rhee, YK
Chung, MJ
Kwak, YG
Lee, YC
机构
[1] Chonbuk Natl Univ Med Sch, Res Inst Clin Med, Dept Internal Med, Chonju 561712, Chonbuk, South Korea
[2] Chonbuk Natl Univ Med Sch, Res Inst Clin Med, Dept Pathol, Chonju 561712, Chonbuk, South Korea
[3] Chonbuk Natl Univ Med Sch, Res Inst Clin Med, Dept Pharmacol, Chonju 561712, Chonbuk, South Korea
关键词
cryptogenic organizing pneumonia; lymphocyte; matrix metalloproteinase-9; neutrophil; tissue inhibitor of metalloproteinase-1; usual interstitial pneumonia;
D O I
10.1378/chest.121.5.1478
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The processes observed in interstitial lung disease are associated with the production, deposition, and proteolysis of the extracellular matrix (ECM), which may lead to irreversible pulmonary structural remodeling or to appropriate repair without fibrosis. Matrix metalloproteinases (MMPs) and a tissue inhibitor of metalloproteinases (TIMPs) are known to regulate remodeling of the ECM and thus to be important in the process of lung fibrosis. Pulmonary structures are extensively remodeled in usual interstitial pneumonia (UIP), whereas severe architectural remodeling is minimally present in cryptogenic organizing pneumonia (COP). However, not much is known about the roles of MMP-9 and/or TIMP-1 in COP. Methods: Levels of MMP-9, TIMP-1 and the molar ratio of MMP-9/TIMP-1 in BAL fluids were investigated in 11 patients with UIP, in 8 patients with COP, and in 10 control subjects. We checked the levels of MMP-9 and TIMP-1 by means of enzyme immunoassay, and the hydrolytic activity of MMP-9 in BAL fluids was measured by gelatin zymography. Further, we evaluated the expression of MMP-9 and TIMP-1 in lung tissue by immunohistochemistry. Results: The concentrations of MMP-9 and TIMP-1 were significantly increased in patients with UIP and were even higher in patients with COP compared with control subjects. The levels of MMP-9 and TIMP-1 were significantly higher in patients with COP than in patients with UIP. The molar ratio of MMP-9/TIMP-1 was significantly higher in patients with COP than in control subjects. In patients with COP, the concentration of MMP-9 significantly correlated with the number of neutrophils and lymphocytes. Zymographic analysis revealed that the activity of the 92-kd pro-MMP-9 was increased in patients with UIP and was even higher in patients with COP, compared with control subjects. Conclusions: These data suggest that overproduction of MMP-9 and TIMP-1, and an imbalance between MMP-9 and TIMP-1, may have a role as diagnostic references in COP.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 50 条
  • [1] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    BRAIN & DEVELOPMENT, 2009, 31 (08) : 588 - 593
  • [2] Expression of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 in childhood acute lymphoblastic leukemia
    Mekawy, Mohamed A.
    Maksoud, Sahar S. Abdel
    Eissa, Doaa G.
    Abdelmaksoud, Abeer A.
    Ragab, Iman A.
    Sallam, Mahmoud T.
    Yousef, Adam A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2012, 37 (04) : 274 - 280
  • [3] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin
    Fiorelli, Alfonso
    Ricci, Serena
    Feola, Antonia
    Mazzella, Antonio
    D'Angelo, Luigi
    Santini, Mario
    Di Domenico, Marina
    Di Carlo, Angelina
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2016, 22 (04) : 411 - 418
  • [4] Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
    Duda, Izabela
    Krzych, Lukasz
    Jedrzejowska-Szypulka, Halina
    Lewin-Kowalik, Joana
    OPEN MEDICINE, 2020, 15 (01): : 50 - 56
  • [5] Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer:: relationship to clinicopathological variables
    Islekel, Huray
    Oktay, Gulgun
    Terzi, Cem
    Canda, Aras Emre
    Fuzun, Mehmet
    Kupelioglu, Ali
    CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (04) : 433 - 441
  • [7] Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis
    Ichiyama, Takashi
    Matsushige, Takeshi
    Siba, Peter
    Suarkia, Dagwin
    Takasu, Toshiaki
    Miki, Kenji
    Furukawa, Susumu
    JOURNAL OF INFECTION, 2008, 56 (05) : 376 - 380
  • [8] CELL DISTRIBUTION DIFFERENCES OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 IN PATIENTS WITH KAWASAKI DISEASE
    Korematsu, Seigo
    Ohta, Yoko
    Tamai, Naotaka
    Takeguchi, Masahiro
    Goto, Chika
    Miyahara, Hiroaki
    Kawano, Tatsuya
    Izumi, Tatsuro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (09) : 973 - 974
  • [9] Modulation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in RAW264.7 cells by irradiation
    Zhou, Y.
    Xia, L.
    Zhou, Y. J.
    He, Z. S.
    Ouyang, W.
    Z, H.
    Zhou, Y. F.
    Xie, C. H.
    MOLECULAR MEDICINE REPORTS, 2010, 3 (05) : 809 - 813
  • [10] Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis
    Mizoue, T
    Kawamoto, H
    Arita, K
    Tominaga, A
    Kurisu, K
    ACTA NEUROCHIRURGICA, 1999, 141 (05) : 481 - 486